Microdosing psychedelics Linked to Healthier Lifestyles,Study Finds
A new study suggests that the practice of taking very small amounts of psychedelics may assist individuals in adopting healthier lifestyles. The research indicates that people who microdose report improvements in sleep, physical activity, and diet, particularly when they start the regimen with a specific goal in mind. These findings regarding the link between low-dose psychedelics and health habits were published in the journal Neuropharmacology.
Chronic diseases such as heart disease and diabetes are responsible for millions of deaths annually. Medical experts agree that these conditions are largely preventable through lifestyle choices like regular exercise and a balanced diet. Though, changing long-standing habits is a tough psychological challenge for many people.
Sustaining a healthy lifestyle requires constant self-regulation and motivation.When these psychological resources are depleted, people often revert to unhealthy behaviors.This struggle has led scientists to look for novel interventions that might make behavioral changes easier to maintain.
Classic psychedelics like psilocybin are known to affect serotonin receptors in the brain. Previous research has shown that high doses of these substances can help treat addiction to alcohol and tobacco. This has led to the concept of “behavioral psychedelics,” which explores how these compounds might foster positive changes in habits.
luisa Prochazkova,a researcher affiliated with the University of Lisbon in Portugal and Leiden University in the Netherlands,led this recent investigation. She and her colleagues sought to understand if the benefits observed in high-dose therapies could also apply to microdosing. Microdosing involves taking a fraction of a standard recreational dose,which is too small to cause hallucinations.
The researchers aimed to characterize the people who use this practice and the specific health shifts they attribute to it. They also wanted to identify the psychological mechanisms that might drive these changes. To do this, the team designed a retrospective mixed-method survey.
The study recruited three hundred and sixty-five participants through online communities and harm-reduction organizations. These participants had experience with microdosing and were willing to share their protocols and outcomes. The average age of the respondents was about forty-five years.
Most of the participants resided in Western countries, with a large number living in the Netherlands. This geographic concentration is relevant as psilocybin truffles are legally accessible in that region.Consequently, truffles were the most commonly used substance among the group.
The survey asked detailed questions about how the participants structured their usage. About half of the group followed the “Fadiman protocol,” which involves taking a dose every third day. Others followed a schedule of dosing for several days in a row followed by a break.
Some participants practiced “stacking,” which involves combining the psychedelic with non-psychedelic supplements. Common additions included Lion’s Mane mushrooms and niacin. The users believed these combinations might enhance the cognitive benefits of the microdose.
The researchers analyzed the data to determine which health behaviors changed the most.Improvements in sleep quality were among the most frequently reported benefits. Nearly half of the participants noted that their sleep had improved since they began microdosing.
Contemplative practices also saw a major boost among the respondents. A similar percentage of users reported that they engaged more frequently in activities like meditation and mindfulness. This suggests that the practice may encourage a greater focus on mental and emotional wellness.
Physical activity was another area where users perceived ample positive shifts. Many participants reported that they exercised more frequently enough or with greater intensity. This included increased engagement in walking, hiking.